Skip Navigation

A Pilot Study of Dinutuximab, Sargramostim GM-CSF, and Isotretinoin in Combination with Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
Feasibility/Pilot

ClinicalTrials.gov Identifier:
NCT04385277

Study #:
CMH - ANBL19P1

Start Date:
Aug 18, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04385277

View Complete Trial Details & Eligibility at ClinicalTrials.gov